2-氧代-1,2-二氢喹啉-8-基 乙酸酯合成路线 (共 14 条)
反应条件
AlCl3, aluminium chloride in dichlorobenzene, 1,2- T=20 - 25°C; 1.66667 h;
参考文献
NOVARTIS AG; NOVARTIS PHARMA GMBH
Patent: WO2004/87668 A1, 2004 ;
Location in patent: Page 27-28 ;
WO 2004/087668 A1
参考文献
Petitjean, Anne; Kyritsakas, Nathalie; Lehn, Jean-Marie
Chemistry - A European Journal, 2005 , vol. 11, # 23 p. 6818 - 6828
参考文献
Moran, Edmund J.; Jacobsen, John R.; Aggen, James B.
Patent: US2003/153597 A1, 2003 ;
反应条件
1: 30percent H2O2, glacial acetic acid / 18 h / 80 °C 2: 67 percent / acetic anhydride / 18 h / 75 °C View Scheme
参考文献
DeRuiter; Brubaker; Whitmer; Stein Jr.
Journal of Medicinal Chemistry, 1986 , vol. 29, # 10 p. 2024 - 2028
反应条件
1: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 2 h / 20 °C / Cooling with ice 2: 2.5 h / 70 °C / Cooling with ice View Scheme
参考文献
TEIJIN PHARMA LIMITED
Patent: US2012/46467 A1, 2012 ;
反应条件
1.1: AlCl3, aluminium chloride / anhydrous dichloroethane / 3 h / 80 °C / Cooling with ice 1.2: 20 °C 2.1: potassium carbonate / N,N-dimethyl-formamide / 2 h / 20 °C 3.1: pyridinium tribromide / tetrahydrofuran / 0 °C / Reflux 4.1: (R)-tetrahydro-1-methyl-3,3-diphenyl-1H,3H-pyrrolo[1,2-c]-[1,3,2]oxazaborole / tetrahydrofuran / 0.67 h / -55 - -45 °C / Inert atmosphere 4.2: -45 - 0 °C / Inert atmosphere 4.3: 20 °C View Scheme
参考文献
TEIJIN PHARMA LIMITED
Patent: US2012/46467 A1, 2012 ;
反应条件
1.1: AlCl3, aluminium chloride / anhydrous dichloroethane / 3 h / 80 °C / Cooling with ice 1.2: 20 °C 2.1: potassium carbonate / N,N-dimethyl-formamide / 2 h / 20 °C View Scheme
参考文献
TEIJIN PHARMA LIMITED
Patent: US2012/46467 A1, 2012 ;
反应条件
1: With hydrogenchloride; AlCl3, aluminium chloride in 1,2-dichloro-ethane T=0 - 85°C; 1.5 h; 2: With hydrogenchloride in water T=0°C; 2 h;
参考文献
Moran, Edmund J.; Jacobsen, John R.; Leadbetter, Michael R.; Nodwell, Matthew B.; Trapp, Sean G.; Aggen, James; Church, Timothy J.
Patent: US2003/229058 A1, 2003 ;
Location in patent: Page 47 ;
US 20030229058 A1
反应条件
AlCl3, aluminium chloride in dichlorobenzene, 1,2- T=80°C; 1 h;
参考文献
NOVARTIS AG; NOVARTIS PHARMA GMBH
Patent: WO2005/123684 A2, 2005 ;
Location in patent: Page/Page column 33-34 ;
参考文献
WO2004/87668 A1, ;
Page 27 ;
WO 2004/087668 A1